Immunomodulation Protocol
Immunomodulation Protocol - Related Videos
09:07
Murine Model of Epicutaneously-Induced Immunomodulation
0 Views •
2025
The study demonstrates the role of the skin in modulating immune responses in mice through epicutaneous (EC) immunization. EC immunization with a protein antigen can suppress immune responses in contact hypersensitivity or reverse skin-induced suppression when combined with pathogen-associated molecular patterns. EC immunization shows promise as an effective, needle-free approach to immunotherapy.
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
0 Views •
Cited by 17 •
2019
This protocol describes a detailed workflow for the generation and ex vivo characterization of oncolytic viruses for expression of immunomodulators, using measles viruses encoding bispecific T cell engagers as an example. Application and adaptation to other vector platforms and transgenes will accelerate the development of novel immunovirotherapeutics for clinical translation.
06:02
Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
0 Views •
Cited by 6 •
2018
Here, we present the protocols to identify 1) virus-encoded immunomodulators that promote arbovirus replication and 2) eukaryotic host factors that restrict arbovirus replication. These fluorescence- and luminescence-based methods allow researchers to rapidly obtain quantitative readouts of arbovirus replication in simplistic assays with low signal-to-noise ratios.
07:12
Neutrophil Isolation Protocol
0 Views •
Cited by 176 •
2008
Neutrophils are among the first cells to arrive on the site of inflammatory immune response, and their functions and mechanisms have been studied extensively in vitro. We demonstrate a standard density gradient separation method to isolate human neutrophils from whole blood using commercially available separation media.
07:56
Parabiosis in Mice: A Detailed Protocol
0 Views •
Cited by 188 •
2013
Parabiotic joining of two organisms leads to the development of a shared circulatory system. In this protocol, we describe the surgical steps to form a parabiotic connection between a wild-type mouse and a constitutive GFP-expressing mouse.
FAQs
Different interventions can shift immunity through cytokine signaling, immune-cell activation, or receptor pathways. Changing one of these control points may alter how strongly immune cells respond, how they coordinate, or how inflammation develops. Identifying the targeted pathway helps investigators connect an observed protective or harmful outcome to a particular mechanism rather than treating immune activity as a single response.
The central design challenge is preserving pathogen clearance while limiting tissue injury. Excessive suppression may weaken protective host defenses, whereas uncontrolled activation can intensify disease-associated inflammation. An effective protocol therefore evaluates both sides of the response: evidence that the intervention supports defense against infection and evidence that it avoids an unnecessarily damaging inflammatory state.
Timing and dosage are mechanistic variables, not merely logistical details. The same immunomodulatory intervention can produce different effects when delivered at different stages or at different amounts, because immune activation and inflammatory signaling change over time. Controlled schedules allow researchers to compare responses systematically and determine whether an outcome reflects the intervention itself or differences in exposure.
A useful plan specifies the intervention, its timing and dosage, the immune process being targeted, and the measurements used to monitor response. Investigators then apply the intervention under controlled conditions and compare immune or disease-related outcomes with the protocol’s intended objective. This structure makes the experiment interpretable and helps reveal whether immune activity shifted in the desired direction.
Immunomodulation protocols support evaluation of vaccines, anti-inflammatory treatments, and adjunctive therapies. In vaccine studies, the focus may be whether immune activity becomes more protective; in anti-inflammatory work, whether harmful activation is reduced; and in adjunctive treatment, whether immune adjustment complements another approach. The relevant outcome depends on the intervention’s purpose and the response being monitored.
In immunology and infection research, these protocols help separate protective host defense from collateral tissue damage. Researchers can examine how altering immune pathways affects the ability to eliminate pathogens while also tracking inflammatory consequences. That paired perspective is important when interpreting treatment results, because improved control of infection alone does not establish that the intervention avoids harmful immune activation.